Townsquare Capital LLC trimmed its position in Haleon plc (NYSE:HLN - Free Report) by 49.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 240,952 shares of the company's stock after selling 234,666 shares during the quarter. Townsquare Capital LLC's holdings in Haleon were worth $2,299,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of HLN. Addison Advisors LLC raised its position in shares of Haleon by 28.7% in the fourth quarter. Addison Advisors LLC now owns 4,954 shares of the company's stock valued at $47,000 after purchasing an additional 1,106 shares during the period. Synovus Financial Corp lifted its position in Haleon by 0.8% during the third quarter. Synovus Financial Corp now owns 148,834 shares of the company's stock worth $1,575,000 after acquiring an additional 1,216 shares during the last quarter. Haverford Trust Co boosted its holdings in shares of Haleon by 5.0% during the fourth quarter. Haverford Trust Co now owns 25,842 shares of the company's stock worth $247,000 after acquiring an additional 1,233 shares during the period. Bessemer Group Inc. lifted its holdings in Haleon by 5.9% during the 4th quarter. Bessemer Group Inc. now owns 22,301 shares of the company's stock worth $212,000 after purchasing an additional 1,236 shares during the last quarter. Finally, FIL Ltd boosted its stake in Haleon by 45.7% in the 4th quarter. FIL Ltd now owns 4,049 shares of the company's stock valued at $39,000 after purchasing an additional 1,270 shares during the period. Institutional investors own 6.67% of the company's stock.
Haleon Stock Up 0.1 %
NYSE HLN traded up $0.02 on Monday, hitting $10.24. 953,546 shares of the company were exchanged, compared to its average volume of 7,126,317. Haleon plc has a 12 month low of $8.12 and a 12 month high of $10.80. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The company has a market cap of $46.22 billion, a PE ratio of 30.16, a PEG ratio of 2.82 and a beta of 0.24. The stock has a fifty day moving average of $10.09 and a 200-day moving average of $9.80.
Haleon (NYSE:HLN - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported $0.05 EPS for the quarter. The business had revenue of $3.54 billion during the quarter, compared to analyst estimates of $3.38 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. As a group, analysts forecast that Haleon plc will post 0.43 earnings per share for the current year.
Haleon Increases Dividend
The firm also recently declared a -- dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be paid a dividend of $0.1166 per share. This represents a yield of 1.6%. The ex-dividend date of this dividend is Friday, April 25th. This is a positive change from Haleon's previous -- dividend of $0.05. Haleon's payout ratio is 58.97%.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on the company. Hsbc Global Res downgraded Haleon from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Haleon in a research report on Monday, March 3rd. HSBC reissued a "hold" rating on shares of Haleon in a research note on Wednesday, March 5th. Morgan Stanley downgraded Haleon from an "overweight" rating to an "equal weight" rating in a research report on Friday, January 10th. Finally, Sanford C. Bernstein lowered Haleon from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 8th. Six research analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $10.95.
Get Our Latest Report on Haleon
About Haleon
(
Free Report)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Featured Articles
Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
